Company intelligence / Profile preview
Mitovie Pharma
Watford, England, United Kingdom
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Mitovie Pharma developed several investigational drugs, with its most advanced asset reaching Phase 1 trials. Clinical data on these programs is limited in the public domain, with available records indicating work on intranasal naloxone and drugs for Parkinson disease and epilepsy. The company's main registered UK entity was dissolved in 2017.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Mitovie Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitovie Pharma.